NASDAQ:CDLA

Candela Medical, Inc. provides medical device solutions for a range of aesthetic applications. The company offers products in the categories of permanent hair reduction, treatment of pigmentation, tattoos, vascular abnormalities, and fractional resurfacing, as well as franchises in skin tightening, fat destruction and cellulite, ablative and non-ablative skin resurfacing and rejuvenation, facial wrinkles, and acne scar reduction. It also provides clinical education and post-sales support to its customers, including clinical training, product technical and service support, and practice marketing. In addition, the company offers on-site device maintenance and repair services, including regularly scheduled maintenance. It markets and sells its solutions to dermatologists, plastic surgeons, aesthetic surgeons, medical aesthetics spas, aesthetic business chains, and other qualified medical and aesthetic practitioners directly in 18 countries, including the United States, China, Japan, and Western Europe, as well as in 66 countries worldwide. Candela Medical, Inc. was founded in 1970 and is headquartered in Marlborough, Massachusetts. Candela Medical, Inc operates as a subsidiary of Dion Topco L.P.